BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31849036)

  • 1. HPV-based cervical cancer screening in low-resource settings: Maximizing the efficiency of community-based strategies in rural Kenya.
    Huchko MJ; Olwanda E; Choi Y; Kahn JG
    Int J Gynaecol Obstet; 2020 Mar; 148(3):386-391. PubMed ID: 31849036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya.
    Shen J; Olwanda E; Kahn JG; Huchko MJ
    BMC Health Serv Res; 2018 May; 18(1):378. PubMed ID: 29801496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.
    Huchko MJ; Ibrahim S; Blat C; Cohen CR; Smith JS; Hiatt RA; Bukusi E
    Int J Gynaecol Obstet; 2018 Apr; 141(1):63-69. PubMed ID: 29197067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study.
    Olwanda E; Shen J; Kahn JG; Bryant-Comstock K; Huchko MJ
    Glob Health Action; 2018; 11(1):1451455. PubMed ID: 29589991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
    Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
    BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the costs of HPV testing through community health campaigns versus home-based testing in rural Western Kenya: a microcosting study.
    Olwanda EE; Kahn JG; Choi Y; Islam JY; Huchko M
    BMJ Open; 2020 Oct; 10(10):e033979. PubMed ID: 33109637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya.
    Huchko MJ; Kahn JG; Smith JS; Hiatt RA; Cohen CR; Bukusi E
    BMC Cancer; 2017 Dec; 17(1):826. PubMed ID: 29207966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Qualitative Exploration of Women's Experiences with a Community Health Volunteer-Led Cervical Cancer Educational Module in Migori County, Kenya.
    Choi Y; Oketch SY; Adewumi K; Bukusi E; Huchko MJ
    J Cancer Educ; 2020 Feb; 35(1):36-43. PubMed ID: 30368651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies.
    Page CM; Ibrahim S; Park LP; Huchko MJ
    PLoS One; 2020; 15(7):e0235264. PubMed ID: 32658921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
    BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and Facilitators to Cervical Cancer Screening in Western Kenya: a Qualitative Study.
    Adewumi K; Nishimura H; Oketch SY; Adsul P; Huchko M
    J Cancer Educ; 2022 Aug; 37(4):1122-1128. PubMed ID: 33411253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
    Campos NG; Tsu V; Jeronimo J; Njama-Meya D; Mvundura M; Kim JJ
    Health Policy Plan; 2017 Sep; 32(7):956-968. PubMed ID: 28369405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Qualitative Exploration of Barriers to Treatment Among HPV-Positive Women in a Cervical Cancer Screening Study in Western Kenya.
    Isaacson S; Adewumi K; Smith JS; Novak C; Oketch S; Huchko MJ
    Oncologist; 2023 Jan; 28(1):e9-e18. PubMed ID: 36239434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia.
    Brandt T; Wubneh SB; Handebo S; Debalkie G; Ayanaw Y; Alemu K; Jede F; von Knebel Doeberitz M; Bussmann H
    BMC Public Health; 2019 Jul; 19(1):1026. PubMed ID: 31366402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female perspectives on male involvement in a human-papillomavirus-based cervical cancer-screening program in western Kenya.
    Adewumi K; Oketch SY; Choi Y; Huchko MJ
    BMC Womens Health; 2019 Aug; 19(1):107. PubMed ID: 31395060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study.
    Page CM; Ibrahim S; Park LP; Huchko MJ
    PLoS One; 2019; 14(9):e0222750. PubMed ID: 31532808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
    Campos NG; Castle PE; Wright TC; Kim JJ
    Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.